Literature DB >> 27629649

Amyloid-β transmission or unexamined bias?

Hieab H H Adams1,2, Sonja A Swanson1,3, Albert Hofman1,3, M Arfan Ikram1,2,4.   

Abstract

Year:  2016        PMID： 27629649     DOI： 10.1038/nature19086

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  12 in total

1.  Decreased plasma insulin-like growth factor-I level in familial Alzheimer's disease patients carrying the Swedish APP 670/671 mutation.

Authors:  A Mustafa; L Lannfelt; L Lilius; A Islam; B Winblad; A Adem
Journal:  Dement Geriatr Cogn Disord       Date:  1999 Nov-Dec       Impact factor: 2.959

2.  Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy.

Authors:  Zane Jaunmuktane; Simon Mead; Matthew Ellis; Jonathan D F Wadsworth; Andrew J Nicoll; Joanna Kenny; Francesca Launchbury; Jacqueline Linehan; Angela Richard-Loendt; A Sarah Walker; Peter Rudge; John Collinge; Sebastian Brandner
Journal:  Nature       Date:  2015-09-10       Impact factor: 49.962

3.  The red-hot debate about transmissible Alzheimer's.

Authors:  Alison Abbott
Journal:  Nature       Date:  2016-03-17       Impact factor: 49.962

Review 4.  Growth hormone and cognitive function.

Authors:  Fred Nyberg; Mathias Hallberg
Journal:  Nat Rev Endocrinol       Date:  2013-04-30       Impact factor: 43.330

5.  Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease.

Authors:  J A Hainfellner; J Wanschitz; K Jellinger; P P Liberski; F Gullotta; H Budka
Journal:  Acta Neuropathol       Date:  1998-08       Impact factor: 17.088

6.  Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type.

Authors:  A Tham; A Nordberg; F E Grissom; C Carlsson-Skwirut; M Viitanen; V R Sara
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1993

7.  Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy.

Authors:  Andrew J Westwood; Alexa Beiser; Charles Decarli; Tamara B Harris; Tai C Chen; Xue-Mei He; Ronenn Roubenoff; Aleksandra Pikula; Rhoda Au; Lewis E Braverman; Philip A Wolf; Ramachandran S Vasan; Sudha Seshadri
Journal:  Neurology       Date:  2014-04-04       Impact factor: 9.910

8.  IGF-1 promotes beta-amyloid production by a secretase-independent mechanism.

Authors:  Wataru Araki; Hideaki Kume; Akiko Oda; Akira Tamaoka; Fuyuki Kametani
Journal:  Biochem Biophys Res Commun       Date:  2009-01-22       Impact factor: 3.575

Review 9.  Role of insulin-like growth factor I signaling in neurodegenerative diseases.

Authors:  José Luis Trejo; Eva Carro; Eva Garcia-Galloway; Ignacio Torres-Aleman
Journal:  J Mol Med (Berl)       Date:  2003-11-28       Impact factor: 4.599

Review 10.  Potential roles of insulin and IGF-1 in Alzheimer's disease.

Authors:  Laura Gasparini; Huaxi Xu
Journal:  Trends Neurosci       Date:  2003-08       Impact factor: 13.837
View more
  4 in total

1.  Voltammetric determination of the Alzheimer's disease-related ApoE 4 gene from unamplified genomic DNA extracts by ferrocene-capped gold nanoparticles.

Authors:  Hanwen Lu; Ling Wu; Jingrui Wang; Zixiao Wang; Xinyao Yi; Jianxiu Wang; Nan Wang
Journal:  Mikrochim Acta       Date:  2018-11-14       Impact factor: 5.833

2.  Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormone.

Authors:  Silvia A Purro; Mark A Farrow; Jacqueline Linehan; Tamsin Nazari; David X Thomas; Zhicheng Chen; David Mengel; Takashi Saito; Takaomi Saido; Peter Rudge; Sebastian Brandner; Dominic M Walsh; John Collinge
Journal:  Nature       Date:  2018-12-13       Impact factor: 49.962

3.  Isotope-labeled amyloid-β does not transmit to the brain in a prion-like manner after peripheral administration.

Authors:  Mirjam Brackhan; Giulio Calza; Kristiina Lundgren; Pablo Bascuñana; Thomas Brüning; Rabah Soliymani; Rakesh Kumar; Axel Abelein; Marc Baumann; Maciej Lalowski; Jens Pahnke
Journal:  EMBO Rep       Date:  2022-05-27       Impact factor: 9.071

4.  Collinge et al. reply.

Authors:  John Collinge; Zane Jaunmuktane; Simon Mead; Peter Rudge; Sebastian Brandner
Journal:  Nature       Date:  2016-09-15       Impact factor: 49.962
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.